headache while on glp 1 Treatment with GLP-1 receptor agonists is associated with significant weight loss and favorable outcomes in idiopathic intracranial hypertension | The Journal of Headache and Pain New study alert 🚨 GLP-1

Once intact bacteria and other antigenic substances cross the intestinal wall, they encounter numerous immune cells that react to these substances, leading to inflammation

Patell, who also serves as chair of NBCAs Council on Emerging Researchers in Thrombosis, found that people taking GLP-1 drugs were 48% less likely to develop deep vein thrombosis or pulmonary embolism compared to those not on these medications

Undiagnosed diabetes

Top panels illustrate mechanisms of action: atropine (2.1 mg) competitively antagonizes acetylcholine at muscarinic receptors to reverse cholinergic effects (e.g., bronchorrhea, bronchospasm, bradycardia), while pralidoxime (2PAM, 600 mg) reactivates acetylcholinesterase by cleaving the nerve agentenzyme bond prior to irreversible aging. Middle panels depict the dualchamber autoinjector design, which contains atropine and pralidoxime in separate compartments and delivers both drugs sequentially via a springloaded intramuscular mechanism from a single needle